Category: Legal Threats

The first weeks of the second Trump administration have brought unprecedented shock and awe to science. In response, the leaders of the scientific community must cease their hand-wringing and align behind two strong approaches to dealing with the chaos: protest and candor.

I write these words as an attorney representing whistleblowers of scientific fraud. Prior to law school, I was an investigative journalist focused on this same phenomenon. Today I represent scientists and technical experts independent of whether the falsified data they have uncovered support a political agenda. Twenty years of experience investigating, exposing and, when necessary, litigating cases of scientific fraud, has, however, led me to think in terms of a different kind of politics: the politics of nonconfirmatory data. Any research-based organization – a university, a healthcare provider, a laboratory or a corporation – faces a daily challenge from data gathered by scientists within that contradict the scientific hypotheses that are bringing in the money.

The authors of three papers about abortion Sage retracted earlier this year have sued the publisher, alleging the company pulled the articles “for pretextual and discriminatory reasons.” 

In February, Sage retracted three articles from Health Services Research and Managerial Epidemiology “because of undeclared conflicts of interest and after expert reviewers found that the studies demonstrate a lack of scientific rigor that invalidates or renders unreliable the authors’ conclusions,” according to the publisher’s statement at the time. Sage also removed the paper’s lead author from the editorial board of the journal. 

A federal judge cited two of the articles last year in his decision to suspend approval of mifepristone, a drug used in medical abortions. 

Proceedings of the National Academy of Sciences has corrected an article by a prize-winning chemist following a report by Retraction Watch his threat to sue a fellow scientist who had submitted a letter to the journal critiquing the paper. 

Chad Mirkin, director of the International Institute for Nanotechnology at Northwestern University in Chicago, received one quarter of this year’s Kavli Prize in nanoscience for his work on spherical nucleic acids (SNAs), the topic of the PNAS article. 

As we reported last month, a lawyer representing Mirkin sent a cease and desist letter to Raphaël Lévy, a professor of physics at the Université Paris Sorbonne Nord, accusing Lévy of making “patently false and defamatory” statements about Mirkin’s research in a letter Lévy had submitted to PNAS about the now-corrected article. 

In his letter, Lévy wrote that the article’s “presentation of SNAs as a ‘powerful class of nanotherapeutics’ is misleading.” 

A journal has republished an edited version of a paper it retracted after a distributor of a chiropractic product the paper criticized wrote in to complain. 

The distributor accused the publication of making “very serious, incorrect and libelous statements” and threatened legal action, Retraction Watch has learned. 

A Frontiers journal has taken down the abstract of a “provisionally accepted” article about harms from an herbal supplement after the company that sells the products sued the first author for defamation. 

The author of the paper, Cyriac Abby Philips, a hepatologist at Rajagiri Hospital in Kerala, India, has over 266,000 followers on his X account “TheLiverDoc.” In 2020, another of Philips’ papers about harm from supplements was retracted and removed after the large supplement company Herbalife, whose products the paper impugned, put legal pressure on Elsevier. 

Himalaya Wellness, an herbal supplement company which says its products are based on Ayurvedic practices, last year sued Philips for defamation based on his posts on X about the company’s products. 

One of the winners of the 2024 Kavli Prize in nanoscience has threatened to sue a longtime critic, Retraction Watch has learned. 

In a cease and desist letter, a lawyer representing Chad Mirkin, a chemist and director of the International Institute for Nanotechnology at Northwestern University in Chicago, accused Raphaël Lévy, a professor of physics at the Université Paris Sorbonne Nord, of making “patently false and defamatory” statements about Mirkin’s research.

The demand primarily concerns a letter to the editor Lévy submitted in April to Proceedings of the National Academy of Sciences regarding an article Mirkin co-authored, “Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy,” which appeared in the journal in February. 

A journal has retracted a letter to the editor and removed the online version from its website “because legal concerns were raised to the Publisher,” according to the notice. The retracted letter had referred to multiple journals as “predatory.” 

The retracted letter, “A threat to scientific integrity,” appeared in the British Dental Journal in August 2023. The author, Niall McGuinness, director of the MClinDent / DClinDent programme in orthodontics at the Edinburgh Dental Institute, criticized a May 2023 opinion article, “What does the Dentists Act say about orthodontic treatment choice?” for the articles it cited.

In particular, McGuinness called out citations to publications in journals “of questionable probity in regard to publication ethics – ‘predatory’ journals as defined by Jeffrey Beall, of the University of Colorado,” according to an archived version seen by Retraction Watch. He listed four journals cited in the article, including one from the publisher Frontiers and another from MDPI, which appeared on Beall’s list.